ArticleFrontiers in medicine2018
A Fatal Bacteremia Caused by Hypermucousviscous KPC-2 Producing Extensively Drug-Resistant K64-ST11
Article in Frontiers in medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 33 citations in OpenAlex.
- Virulence plasmid with IroBCDN deletion promoted cross-regional transmission of ST11-KL64 carbapenem-resistant hypervirulent Klebsiella pneumoniae in central China.BMC microbiology · 2024Article
- Long-term occurrence of multiple antimicrobial drug resistant Klebsiella pneumoniae isolates harboring virulent potential in a tertiary hospital from Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024Article
- Article
- Successful treatment of invasive liver abscess syndrome caused byWorld journal of gastrointestinal surgery · 2023Article
- Clinical Spectrum and Outcomes of CryptogenicPathogens (Basel, Switzerland) · 2023Article
- Emergence of Carbapenemase-Producing Hypervirulent Klebsiella pneumoniae in Switzerland.Antimicrobial agents and chemotherapy · 2023Article
- Emergence of colistin-resistant hypervirulentEmerging microbes & infections · 2022Article
- Convergence of two serotypes within the epidemic ST11 KPC-producing Klebsiella pneumoniae creates the "Perfect Storm" in a teaching hospital.BMC genomics · 2022Article
- Multidrug-resistant Klebsiella pneumoniae: a retrospective study in Manaus, Brazil.Archives of microbiology · 2022Article
- Report of a Fatal Purulent Pericarditis Case Caused by ST11-K64 Carbapenem-Resistant HypervirulentInfection and drug resistance · 2022Article
- Clinical evolution of ST11 carbapenem resistant and hypervirulent Klebsiella pneumoniae.Communications biology · 2021Article
- Transmission Dynamics of Carbapenem-ResistantFrontiers in microbiology · 2021Article
- A Novel Multidrug Resistant, Non-TnFrontiers in microbiology · 2021Article
- Molecular Epidemiological Analysis of ST11-K64 Extensively Drug-ResistantFrontiers in microbiology · 2021Article
- Multidrug-Resistant (MDR)Frontiers in microbiology · 2021Article
- Carbapenemase-ProducingFrontiers in microbiology · 2020Article
- Co-occurrence of Rapid Gene Gain and Loss in an Interhospital Outbreak of Carbapenem-Resistant Hypervirulent ST11-K64Frontiers in microbiology · 2020Article
- Emergence of NDM-5-Producing Carbapenem-ResistantInfection and drug resistance · 2020Article
- Molecular Epidemiology of and Risk Factors for Extensively Drug-ResistantFrontiers in pharmacology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 4 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a fatal bacteremia caused by
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.